mTeSR™ Plus

cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells
Catalog #
100-0276_C
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells
From: 315 USD
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

Overview

Enjoy weekend-free schedules and enhanced growth characteristics while maintaining cell quality with this stabilized feeder-free maintenance medium for human pluripotent stem cells (hPSCs).

Manufactured under relevant cGMPs, mTeSR™ Plus ensures the highest quality and consistency for fundamental research as well as for cell therapy and investigational new drug research applications. It is based on mTeSR™1 (Catalog #85850), the most widely published feeder-free cell culture medium for hPSCs. With stabilized critical medium components, including FGF2, and enhanced pH buffering, you can use mTeSR™ Plus to maintain cell-quality attributes and increase cell expansion rates with either daily or restricted feeding. Each lot of mTeSR™ Plus 5X Supplement is used to prepare complete mTeSR™ Plus medium and then performance-tested in a culture assay using human pluripotent stem cells (hPSCs).

mTeSR™ Plus is compatible with a variety of culture matrices, including Corning® Matrigel® hESC-Qualified Matrix and Vitronectin XF™ (Catalog #07180, developed and manufactured by Nucleus Biologics).

For additional quality information, visit www.stemcell.com/compliance.

Advantages
⦁ Enhanced buffering and stabilized FGF2 support cell quality while allowing for alternate feeding schedules
⦁ Supports superior culture morphology and cell growth characteristics
⦁ Enables heightened single-cell survival when used with CloneR™
⦁ Fully compatible with established genome editing and differentiation protocols
Components
  • mTeSR™ Plus Kit, cGMP (Catalog #100-0276)
    • mTeSR™ Plus Basal Medium, 400 mL
    • mTeSR™ Plus 5X Supplement, 100 mL
Subtype
Specialized Media
Cell Type
Pluripotent Stem Cells
Species
Human
Application
Cell Culture, Expansion, Maintenance
Brand
TeSR
Area of Interest
Disease Modeling, Drug Discovery and Toxicity Testing, Stem Cell Biology
Formulation
Serum-Free

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
mTeSR™ Plus
Catalog #
100-0276
Lot #
All
Language
English
Document Type
Manual
Product Name
mTeSR™ Plus
Catalog #
100-0276
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
mTeSR™ Plus
Catalog #
100-0276
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
mTeSR™ Plus
Catalog #
100-0276
Lot #
All
Language
English

Educational Materials (43)

Brochure
mTeSR™ Plus Product Overview Flyer
Brochure
cGMP mTeSR™1
Brochure
2019-2020 Cell Culture Training Catalog
Brochure
mTeSR™ Plus Product Overview Booklet
Brochure
Products for Human Pluripotent Stem Cells
Technical Bulletin
Outsource Your Characterization and Banking of Human Pluripotent Stem Cells
Wallchart
Pluripotent Stem Cell Biology
Wallchart
Derivation and Applications of Human Pluripotent Stem Cells
Wallchart
Directed Differentiation of Pluripotent Stem Cells
Video
How to Maintain and Assess Morphology of Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
3:35
How to Maintain and Assess Morphology of Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
Video
How to Transition Human Pluripotent Stem Cells into mTeSR™ Plus from Other Feeder-Free Media
1:29
How to Transition Human Pluripotent Stem Cells into mTeSR™ Plus from Other Feeder-Free Media
Video
STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
28:27
STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
Video
How to Coat Plates for Human Pluripotent Stem Cell (hPSC) Cultures in mTeSR™ Plus
5:20
How to Coat Plates for Human Pluripotent Stem Cell (hPSC) Cultures in mTeSR™ Plus
Video
How to Generate Cell Aggregates and Passage Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
7:57
How to Generate Cell Aggregates and Passage Human Pluripotent Stem Cells (hPSCs) in mTeSR™ Plus
Video
How to Count hPSC Aggregates to Determine Plating Density for Maintenance and Differentiation
3:39
How to Count hPSC Aggregates to Determine Plating Density for Maintenance and Differentiation
Webinar
Development, Compatibility, and Applications of mTeSR™ Plus; an Enhanced Medium for the Maintenance of Human Pluripotent Stem Cells (hPSCs)
42:10
Development, Compatibility, and Applications of mTeSR™ Plus; an Enhanced Medium for the Maintenance of Human Pluripotent Stem Cells (hPSCs)
Webinar
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
1:13:44
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
Webinar
Best Practice Criteria for Pluripotent Stem Cell Lines
55:52
Best Practice Criteria for Pluripotent Stem Cell Lines
Webinar
Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells
15:47
Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells
Webinar
Nature Research Round Table: Identifying Acquired and Background Genetic Variants in Human Pluripotent Stem Cells
16:56
Nature Research Round Table: Identifying Acquired and Background Genetic Variants in Human Pluripotent Stem Cells
Webinar
Nature Research Round Table: HLA Typing Considerations for Human Pluripotent Stem Cell Banking
13:01
Nature Research Round Table: HLA Typing Considerations for Human Pluripotent Stem Cell Banking
Webinar
Survey Results: Insights and Trends in Pluripotent Stem Cell Research
13:58
Survey Results: Insights and Trends in Pluripotent Stem Cell Research
Webinar
Nature Research Round Table: Pluripotency Tests
17:46
Nature Research Round Table: Pluripotency Tests
Webinar
Human Pluripotent Stem Cells for the Treatment of Age-Related Macular Degeneration and Compliance Considerations for Clinical-Grade iPSCs
47:23
Human Pluripotent Stem Cells for the Treatment of Age-Related Macular Degeneration and Compliance Considerations for Clinical-Grade iPSCs
Webinar
Genetic Stability of Human Pluripotent Stem Cells
54:15
Genetic Stability of Human Pluripotent Stem Cells
Webinar
Improving Reproducibility of Your hPSC Research by Generating a High-Quality Cell Bank
21:53
Improving Reproducibility of Your hPSC Research by Generating a High-Quality Cell Bank
Webinar
Nature Research Round Table: Best Practices for the QC of Genome-Edited hPSC Lines - Panel Discussion
31:25
Nature Research Round Table: Best Practices for the QC of Genome-Edited hPSC Lines - Panel Discussion
Webinar
Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells
17:45
Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells
Webinar
Nature Research Round Table: Standards for Pluripotent Stem Cell Banking
13:02
Nature Research Round Table: Standards for Pluripotent Stem Cell Banking
Webinar
Lost in Translation - Moving Your Research to Clinical Trials
59:01
Lost in Translation - Moving Your Research to Clinical Trials
Webinar
Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro
20:09
Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro
Webinar
Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
1:00:11
Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
Webinar
Data Quality and Standards for Pluripotent Stem Cells
45:22
Data Quality and Standards for Pluripotent Stem Cells
Webinar
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
50:01
Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
Webinar
Cerebral Organoids as 3D, Stem Cell-Derived Models of Tuberous Sclerosis Complex
43:00
Cerebral Organoids as 3D, Stem Cell-Derived Models of Tuberous Sclerosis Complex
Webinar
Nature Research Round Table: The Process of Human Pluripotent Stem Cell Adaptation
18:48
Nature Research Round Table: The Process of Human Pluripotent Stem Cell Adaptation
Webinar
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
33:47
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Webinar
Serum- and Feeder-Free Differentiation of Erythroid Progenitor Cells from hPSCs
31:39
Serum- and Feeder-Free Differentiation of Erythroid Progenitor Cells from hPSCs
Webinar
Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
21:35
Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
Webinar
ISSCR Innovation Showcase: Advanced Brain Organoid Co-Culture Systems
1:01:37
ISSCR Innovation Showcase: Advanced Brain Organoid Co-Culture Systems
Scientific Poster
A Simple, Reproducible Method to Generate Red Blood Cells From Human Pluripotent Stem Cells
Scientific Poster
Culture of High-Quality Human Pluripotent Stem Cells with Versatile Workflows Using mTeSR™ Plus, a New Stabilized TeSR™ Maintenance Medium
Scientific Poster
Modifications Designed to Stabilize the mTeSR1™ Formulation Do Not Impact Downstream Differentiation
Load More Educational Materials

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Data and Publications

Data

Figure 1. mTeSR™ Plus Maintains Optimal pH Levels Throughout a Weekend-Free Protocol

The pH of spent medium from hPSCs cultured in mTeSR™ Plus is higher than that of hPSCs cultured in mTeSR™1 and other flexible-feeding medium at similar cell densities. pH and cell numbers were measured after a 72-hour period without feeding. Range of cell numbers shown represent different densities that would be observed throughout a typical passage. This demonstrates that feeds can be skipped for two days at any time during routine maintenance using mTeSR™ Plus while maintaining a pH above 7.0. Note: Cultures were fed double the standard medium volume prior to the 72-hour period without feeds in all media and cell numbers are from one well of a 6-well plate.

Figure 2. mTeSR™ Plus Maintains Consistent Levels of FGF2 Throughout a Weekend-Free Protocol

FGF2 levels remain high in mTeSR™ Plus when cultured at 37°C over a 72 hour time period. Measured by ELISA.

Figure 3. mTeSR™ Plus Supports Higher Cell Numbers

Growth curves were obtained for human ES (H9) cells cultured in mTeSR™1 or mTeSR™ Plus on Corning® Matrigel® matrix over 7 days with either daily feeds or restricted feeds. Growth curves were determined by seeding 20,000 cells per well of a 6-well plate as aggregates and counting the cell numbers each day in duplicate wells.

Figure 4. Larger Colonies are Observed in mTeSR™ Plus Cultures

The average colony size per passage (± SEM) was obtained for human ES (H1, H9) and iPS (STiPS-M001, WLS-1C) cells cultured in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds) on Corning® Matrigel® over 10 passages. Size was determined by measuring representative colony diameters at harvest. Note that this data is representative of cultures passaged at a 7-day passaging interval; smaller colony size should be expected if using shorter passaging intervals.

Figure 5. Normal human ES and iPS Cell Morphology is Observed in mTeSR™ Plus Cultures

Images depict undifferentiated human hES (H1) and iPS (WLS-1C) cells cultured on Corning®️ Matrigel®️ matrix in mTeSR™1 with daily feeds or mTeSR™ Plus with restricted feeds. Cells retain the prominent nucleoli and high nuclear-to-cytoplasmic ratio characteristic of this cell type after 10 passages. Densely packed cells and multi-layering are prominent when cells are ready to be passaged.

Figure 6. Cells Cultured in mTeSR™ Plus Medium with Restricted Feeding Express Undifferentiated Cell Markers

Human ES (H1, H9) and iPS (WLS-1C, STiPS-M001) cells were characterized using flow cytometry for undifferentiated cell markers, (A) OCT3/4 and (B) TRA-1-60. Graphs show average expression (± SEM) results from analyses of duplicate wells every 5 passages for up to 10-15 passages in mTeSR™1 (daily feeds), or mTeSR™ Plus (restricted feeds).

Figure 7. Cells Maintained in mTeSR™ Plus with Restricted Feeding Have Comparable Differentiation Efficiencies to Cells Maintained in mTeSR™1

Human ES (H1, H9) and iPS (WLS-1C, STiPS-M001) cells were maintained in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds). Cells were differentiated using directed differentiation protocols and subjected to flow cytometry analysis. Graphs show average expression (± SEM) results from the 4 cell lines. The markers used for flow cytometry for each germ layer are listed in the bar titles.

Figure 8. hPSCs Cultured in mTeSR™ Plus with Restricted Feeding Maintain a Normal Karyotype

Karyograms of (A) human ES (H1) and (B) iPS (WLS-1C) cells cultured in mTeSR™ Plus for 30 passages shows a normal karyotype is retained.

Figure 9. High Cloning Efficiency of hPSCs in mTeSR™ Plus Supplemented with CloneR™

hPSCs (H1, H9, WLS-1C, and STiPS-M001) plated in mTeSR™ Plus with CloneR™ demonstrate cloning efficiencies equal to or greater than hPSCs in mTeSR™1 with CloneR™. Cells were seeded at clonal density (25 cells/cm²) in mTeSR™1 or mTeSR™ Plus on CellAdhere™ Vitronectin™ XF™-coated plates. n ≧ 3 biological replicates.

Cell morphology images of ES cells plated in  mTeSR™1 and mTeSR™ Plus and supplemented with CloneR™ immediately following RNP electroporation.

Figure 10. Representative Cell Morphology 24 Hours After RNP Electroporation in mTeSR™1 and mTeSR™ Plus

H1-eGFP ES cells were plated in (A) mTeSR™1 and (B) mTeSR™ Plus and supplemented with CloneR™ immediately following RNP electroporation. Images were taken 24 hours after electroporation.

Cell images of human ES colonies plated in mTeSR™1 and mTeSR™ Plus and supplemented with CloneR™ on CellAdhere™ Vitronectin™ XF™-coated plates.

Figure 11. Clones Derived in mTeSR™ Plus are Larger and Ready to Be Picked at an Earlier Timepoint

Representative images of human ES (H9) colonies taken 8 days following singlecell plating at clonal density (25 cells/cm²) in either (A) mTeSR™1 or (B) mTeSR™ Plus supplemented with CloneR™ on CellAdhere™ Vitronectin™ XF™-coated plates.

Cell morphology images of neural progenitor cells maintained in mTeSR™1 or mTeSR™ Plus. Arrowheads point to clearly displayed neural rosettes after replating embryoid bodies.

Figure 12. Generation of Neural Progenitor Cells from hPSCs Maintained in mTeSR™ Plus

Human ES (H9) and iPS (STiPS-M001) cells were maintained in (A) mTeSR™1 with daily feeds or (B) mTeSR™ Plus with restricted feeds and differentiated using an embryoid body (EB)-based protocol with STEMdiff™ SMADi Neural Induction Kit. Neural progenitor cells derived from hPSCs maintained in either mTeSR™1 or mTeSR™ Plus clearly display neural rosettes (arrowheads) after replating EBs.

Immunocytochemistry image of a cerebral organoid cultured in mTeSR™ Plus and directed to cerebral organoids using the STEMdiff™ Cerebral Organoid Kit.

Figure 13. Generation of Cerebral Organoids from hPSCs Maintained in mTeSR™ Plus

Human ES (H9) cells were cultured with mTeSR™ Plus and directed to cerebral organoids using the STEMdiff™ Cerebral Organoid Kit. Image shows apical progenitor marker SOX2 (purple) and neuronal marker TBR1 (green).

Density plots showing CD34+ and CD45+ expression and percentage of cells co-expressing CD34+ and CD45+ and graphs showing total number of viable cells harvested.

Figure 14. Generation of Hematopoietic Progenitor Cells from hPSCs Maintained in mTeSR™ Plus

Human ES (H1, H9) and iPS (STiPS-M001, WLS-1C) cell lines maintained in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds) were differentiated to hematopoietic progenitor cells using the STEMdiff™ Hematopoietic Kit. At the end of the differentiation period, cells were harvested from the supernatant and analyzed by flow cytometry for co-expression of CD34+ and CD45+ . (A) Representative density plots showing CD34+ and CD45+ expression, (B) percentage of cells co-expressing CD34+ and CD45+ , and (C) total number of viable cells harvested are shown. Data are expressed as the mean (± SEM); n=4.

Microelectrode array and flow cytometry of human ES and iPS cells maintained in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds) and differentiated to cardiomyocytes using the STEMdiff™ Cardiomyocyte Differentiation Kit.

Figure 15. Generation of Cardiomyocytes from hPSCs Maintained in mTeSR™ Plus

Human ES (H9) and iPS (WLS-1C) cells were maintained in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds) and differentiated to cardiomyocytes using the STEMdiff™ Cardiomyocyte Differentiation Kit. At the end of the differentiation period, cells were harvested and analyzed by microelectrode array (MEA) and flow cytometry. (A) Representative MEA voltage recordings of cardiomyocytes (day 20) demonstrate a characteristic electrical profile and stable beat rate. (B) Percentages of cells expressing cTNT and (C) total number of viable cells harvested are shown. Data are expressed as the mean (± SEM); n=2.

Immunocytochemistry image of an intestinal organoid cultured in mTeSR™ Plus and directed to intestinal organoids using the STEMdiff™ Intestinal Organoid Kit.

Figure 16. Generation of Intestinal Organoids from hPSCs Maintained in mTeSR™ Plus

Human ES (H9) cells were cultured with mTeSR™ Plus and directed to intestinal organoids using the STEMdiff™ Intestinal Organoid Kit. Image shows markers of the intestinal epithelium EpCAM (green) and CDX2 (red), and intestinal mesenchyme marker vimentin (white). Nuclei are counterstained with DAPI (blue).

Density plots and quantitative analysis showing CXCR4 and SOX17 expression in cells cultured in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds), following 5 days of differentiation using the STEMdiff™ Definitive Endoderm Kit.

Figure 17. Generation of Definitive Endoderm from hPSCs Maintained in mTeSR™ Plus

(A) Representative density plots showing CXCR4 and SOX17 expression in cells cultured in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds), following 5 days of differentiation using the STEMdiff™ Definitive Endoderm Kit. (B) Quantitative analysis of definitive endoderm formation in multiple hPSC lines (H9, STiPS-M001, WLS-1C) maintained with mTeSR™1 or mTeSR™ Plus as measured by co-expression of CXCR4 and SOX17. Data are expressed as the mean percentage of cells (± SEM) expressing both markers; n=3.

Density plots and quantitative analysis showing PDX-1 and NKX6.1 expression in cells cultured in mTeSR™1 or mTeSR™ Plus, following 5 days of differentiation using the STEMdiff™ Pancreatic Progenitor Kit.

Figure 18. Generation of Pancreatic Progenitors from hPSCs Maintained in mTeSR™ Plus

(A) Representative density plots showing PDX-1 and NKX6.1 expression in cells cultured in mTeSR™1 (daily feeds) or mTeSR™ Plus (restricted feeds), following differentiation using the STEMdiff™ Pancreatic Progenitor Kit. (B) Quantitative analysis of pancreatic progenitor formation in multiple hPS (H9, STiPS-M001, WLS-1C) cell lines maintained with mTeSR™1 or mTeSR™ Plus as measured by co-expression of PDX-1 and NKX6.1. Data are expressed as the mean percentage of cells (± SEM) expressing both markers; n=3.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.